Navigation Links
Multi-Pronged Therapeutic Cancer Vaccine Regimen to be Studied in Melanoma Patients
Date:9/17/2008

nts include financial projections and estimates and their underlying assumptions, statements regarding plans, objectives, intentions and expectations with respect to future events, operations, products and services, and statements regarding future performance. Forward-looking statements are generally identified by the words "expects," "anticipates," "believes," "intends," "estimates," "plans" and similar expressions. Although sanofi-aventis' management believes that the expectations reflected in such forward-looking statements are reasonable, investors are cautioned that forward-looking information and statements are subject to various risks and uncertainties, many of which are difficult to predict and generally beyond the control of sanofi-aventis, that could cause actual results and developments to differ materially from those expressed in, or implied or projected by, the forward-looking information and statements. These risks and uncertainties include those discussed or identified in the public filings with the SEC and the AMF made by sanofi-aventis, including those listed under "Risk Factors" and "Cautionary Statement Regarding Forward-Looking Statements" in sanofi-aventis' annual report on Form 20-F for the year ended December 31, 2007. Other than as required by applicable law, sanofi-aventis does not undertake any obligation to update or revise any forward-looking information or statements.

Global Media Relations U.S. Media Relations

Pascal Barollier Len Lavenda

T. +33-(0)4-37-37-50-38 T. +1-570-839-4446

Pascal.barollier@sanofipasteur.com len.lavenda@sanofipasteur.com

http://www.sanofipasteur.com http://www.sanofipasteur.us
'/>"/>

SOURCE sanofi pasteur
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
2. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
3. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
4. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
5. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
6. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
7. Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
8. TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel
9. Zila Inc. Product Selected to Identify Pre-Cancer in Study of Leading Cancer Treatment Chemotherapeutic - ERBITUX
10. Advanced Life Sciences to Present Data on Selected Cethromycin Therapeutic Studies at the 47th Interscience Conference on Antimicrobial Agents and Chemotherapy
11. TorreyPines Therapeutics Completes Phase I Multiple Dose Clinical Trial of NGX267, a Selective M1 Agonist for the Potential Treatment of Cognitive Impairment Associated with Schizophrenia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)...   Royal Philips (NYSE: ... received 510(k) clearance from the U.S. Food and ... for Transcatheter Aortic-Valve Implantation (TAVI) treatments. Through 3D ... pre-procedural, high-precision positioning to treat aortic stenosis ailments.  ... available as part of Philips IntelliSpace Portal ...
(Date:8/21/2014)... Asterias Biotherapeutics, Inc. (OTCBB: ASTY), a leading ... announced today the appointments of Andrew ("Andy") Arno and ... of Directors. With these additions, the Asterias Board of ... independent. Andy Arno , 55, has ... He is currently Managing Director of Emerging Growth Equities, ...
(Date:8/20/2014)... , Aug. 20, 2014  The National ... the latest results achieved by the real-time, pseudoephedrine ... the National Precursor Log Exchange (NPLEx), automatically blocks ... track down meth offenders and make arrests. Data ... Indiana blocked the sale of ...
Breaking Medicine Technology:Philips receives FDA 510(k) Clearance for TAVI Precision Treatment Planning Application 2Philips receives FDA 510(k) Clearance for TAVI Precision Treatment Planning Application 3Asterias Biotherapeutics Appoints Two Independent Directors and Announces Completion of Series A Common Stock Distribution 2Asterias Biotherapeutics Appoints Two Independent Directors and Announces Completion of Series A Common Stock Distribution 3Asterias Biotherapeutics Appoints Two Independent Directors and Announces Completion of Series A Common Stock Distribution 4Indiana's Stop-Sale System Achieves Significant Results In Battle Against Meth 2
... 25, 2007 /PRNewswire-FirstCall/ --,Genaera Corporation today announced ... (MSI-1436) for the treatment of obesity were,presented ... Sessions, June 22-25 in Chicago, IL. Dr. ... of Abstract #1801-P,presented, "Trodusquemine is a Multiple ...
... 25, 2007 - Gilead,Sciences, Inc. (Nasdaq:GILD) today ... trial evaluating the company's once-daily,anti-HIV drug Viread(R) ... as a potential treatment for chronic hepatitis ... endpoint. The data show,that Viread is non-inferior ...
Cached Medicine Technology:Genaera Presents Preclinical Data on Trodusquemine (MSI-1436) for,the Treatment of Obesity at the American Diabetes Association 67th,Scientific Session 2Genaera Presents Preclinical Data on Trodusquemine (MSI-1436) for,the Treatment of Obesity at the American Diabetes Association 67th,Scientific Session 3Genaera Presents Preclinical Data on Trodusquemine (MSI-1436) for,the Treatment of Obesity at the American Diabetes Association 67th,Scientific Session 4Second Phase III Study Evaluating Gilead's Viread for the Treatment,of Chronic Hepatitis B Virus Meets Primary Endpoint 2Second Phase III Study Evaluating Gilead's Viread for the Treatment,of Chronic Hepatitis B Virus Meets Primary Endpoint 3Second Phase III Study Evaluating Gilead's Viread for the Treatment,of Chronic Hepatitis B Virus Meets Primary Endpoint 4Second Phase III Study Evaluating Gilead's Viread for the Treatment,of Chronic Hepatitis B Virus Meets Primary Endpoint 5Second Phase III Study Evaluating Gilead's Viread for the Treatment,of Chronic Hepatitis B Virus Meets Primary Endpoint 6
(Date:8/21/2014)... Recently, Top10BestSEOHosting.com has compared many professional SEO hosting ... of the most reliable suppliers for webmasters who want ... a boom in websites in recent years, and the ... number of web hosting companies that offer a variety ... has been providing hosting solutions to thousands of business ...
(Date:8/21/2014)... UWDress.com, a well-known wedding dress manufacturer, has added a new ... store. In addition to this, all these beautiful gowns are ... at the moment. The special offer will last from this ... workers have updated its online category with these affordable, elegant ... is a one stop place where worldwide people can buy ...
(Date:8/21/2014)... 2014 Recently, Skmen.com, a distinguished garment supplier, ... girls’ casual dresses . From today until August ... 30 percent off) when they are shopping at the company’s ... outfits are according to the newest quality standards; they are ... charming casual dresses, worldwide ladies can also access the other ...
(Date:8/21/2014)... iFitDress.com, a famous online supplier of wedding dresses and women’s ... range of plus size evening dresses for 2014 . ... these fashionable gowns are available at discounted rates, up to ... are very proud to unveil the new plus size evening ... of fashionable outfits at affordable rates. They are all carefully ...
(Date:8/21/2014)... 2014 AVEC Health Solutions, LLC, ... addition of Kerry Gillespie as Chief Executive Officer. ... experience, Gillespie brings an extremely robust background to ... positions with prominent industry leading organizations across the ... of Triad Isotopes, Inc. a private nuclear pharmaceutical ...
Breaking Medicine News(10 mins):Health News:Best SEO Hosting Suppliers in the Global Market Recommended by Top10BestSEOHosting.com 2Health News:Beautiful Peacock Party Dresses for 2014 Offered by UWDress.com at the Moment 2Health News:Charming Girls’ Casual Dresses Now Released by Distinguished Garment Company Skmen.com 2Health News:iFitDress.com: Cheap Plus Size Evening Dresses for 2014 Now Available 2Health News:Kerry Gillespie Appointed as Chief Executive Officer of AVEC Health Solutions 2
... residents,neuroscience researchers, and interested clinicians will each have,opportunities ... of stroke during the Texas Brain and Spine ... year,s symposium will consist of a,morning presentation for ... researchers. The speakers are both neuroscience specialists who ...
... online community, for people who support affordable health insurance options ... ... While politicians dispense,their health care ideas at party conventions and ... common place to do so is at,AffordableHealthInsurance.NET -- a new social ...
... Lance Armstrong, cancer,survivor, founder and chairman of the Lance ... regarding his return to,professional sports:, "I am happy ... family,and my closest friends, I have decided to return ... global cancer burden. This year alone,nearly eight million people ...
... Pa., Sept. 9 Encorium Group, Inc.,(Nasdaq: ... organization,(CRO) conducting studies in over 30 countries for ... today announced that it,has entered into an amendment ... Research International, Inc. ("Prologue"). Pursuant to the,Amendment, the ...
... women between the ages of 40 and 59 could substantially ... in the September 9 online issue of the Journal ... programs are regularly used in developed countries where the incidence ... system is in place. The value and practicality of such ...
... A narrow region on chromosome 15 contains genetic variations ... conducted by scientists at Washington University School of Medicine ... States and the United Kingdom. , The researchers found ... cancer for people who have both a family history ...
Cached Medicine News:Health News:Texas Brain and Spine Institute to Hold Second Annual Neuroscience Symposium 2Health News:Social Network for Affordable Health Care Supporters Stimulates a New Level of Interactivity and Dialogue 2Health News:Prologue Acquisition Update and Termination of Linkcon Business Combination 2Health News:Prologue Acquisition Update and Termination of Linkcon Business Combination 3Health News:Prologue Acquisition Update and Termination of Linkcon Business Combination 4Health News:Prologue Acquisition Update and Termination of Linkcon Business Combination 5Health News:Breast cancer screening may lower mortality and disease burden in India 2Health News:Genetic region linked to a 5 times higher lung cancer risk 2Health News:Genetic region linked to a 5 times higher lung cancer risk 3
... engineered to set a new standard for ... enter the patient demographics, select auto report ... based system uses the latest in software ... of the IQmark Holter algorithm. Simple, intuitive ...
... your patients' remarkable skin Transformation in less than ... common alpha-hydroxy peels or other superficial procedures, the ... hands - yours. Based on your patients' particular ... of Tricloracetic Acid (TCA) peels and number of ...
... Smoothie is deliciously refreshing scrub ... the use of a gentle ... exfoliate the skin to restore ... irritation. This light chemical peel ...
... rapid exfoliator. Lactic Acid is is recommended for ... agents in skin care products, as well as ... long period and want to improve results. ,Lactic ... combined with the chemical free style of Peel ...
Medicine Products: